Management of multiple myeloma during COVID-19 pandemic
At the end of 2019, a novel coronavirus was identified as the cause of pneumonia cases in Wuhan, a city in the Hubei Province of China. On January 30, 2020, the World Health Organization (WHO) declared the COVID-19 outbreak a public health emergency of international concern and, in March 2020, began...
Main Authors: | YS Jethava, Rafael Fonseca, Ola Landgren |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | Leukemia Research Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213048920300182 |
Similar Items
-
Expert Council resolution on the specifics of multiple myeloma therapy during COVID-19 pandemic
by: Article Editorial
Published: (2020-07-01) -
Multiple Myeloma Management in COVID-19 Era
by: Andree Kurniawan, et al.
Published: (2021-01-01) -
Managing patients with multiple myeloma during the COVID-19 pandemic: recommendations from an expert panel – ABHH monoclonal gammopathies committe
by: Vania Hungria, et al.
Published: (2020-07-01) -
Managing anxiety among multiple sclerosis patients during COVID-19 pandemic
by: Iman Adibi, et al.
Published: (2021-01-01) -
Management of Agitation During the COVID-19 Pandemic
by: Ambrose H. Wong, et al.
Published: (2020-07-01)